You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
NEWS / EVENTS / .........

EVENTS - 02-10-2018

Kedrion Biopharma participates in the Mother and Child Conference in Moscow

The campaign commemorating 50 years of Anti-D was presented at the nineteenth edition of the Mother and Child Conference (Moscow, 26-28 September), the most important scientific-educational congress of the Russian Federation in the area of Gynecology and Obstetrics. The conference, which is organized every year by the Kulakov Research Center for Obstetrics, Gynecology, and Perinatology, in collaboration with the Ministry of Health, the Russian Society of Obstetrics and Gynecology and the Russian Association of Obstetrics, was attended by over 4,000 clinicians.

Aimed at extending the awareness of Anti-D prophylaxis, a Kedrion-supported scientific symposium was dedicated to the “Prevention and Treatment of Hemolytic Disease of the Newborn. Successes Achieved and Objective Difficulties”. Before an audience made of the main Russian experts in this field, Prof. Alexander Konoplyannikov, Main Gynecologist of the Department of Healthcare of the City of Moscow, gave a speech on 50 years of global immunization compared to the Russian experience. Dr. Stanislav Pavlovich, Deputy Director of the Kulakov Center, discussed possible approaches for the prevention of Rh incompatibility and Dr. Maria Vinogradova, Head of the Department of Reproductive Hematology and Hemostasis of the Kulakov Center, delivered a presentation on Hemolytic Disease of the Newborn from the aspect of clinical immunology and hematology.

Providing information on the unbranded global educational 50th anniversary campaign, Kedrion’s booth was visited by more than a 1000 attendees over the congress’ three days, proof of the Russian medical community’s growing awareness of anti-D prophylaxis.

For more information please contact: pressoffice@kedrion.com